Dar Al-Shifa Pharmaceuticals Company Stock

Equities

PHARMACARE

PS2014112861

Pharmaceuticals

End-of-day quote Palestine Exchange 06:00:00 2022-12-18 pm EST 5-day change 1st Jan Change
3.35 USD +4.69% Intraday chart for Dar Al-Shifa Pharmaceuticals Company -.--% -.--%
Sales 2020 23.02M Sales 2021 30.71M Capitalization 28.36M
Net income 2020 2M Net income 2021 4M EV / Sales 2020 2.3 x
Net Debt 2020 22.85M Net Debt 2021 21.03M EV / Sales 2021 1.61 x
P/E ratio 2020
10.5 x
P/E ratio 2021
5.83 x
Employees 423
Yield 2020
2.86%
Yield 2021
3.03%
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
3 years
2.86
Extreme 2.8551
3.35
5 years
2.86
Extreme 2.8551
3.44
10 years
2.86
Extreme 2.8551
3.81
More quotes
Managers TitleAgeSince
Chief Executive Officer - 85-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 48 -
Director/Board Member 62 -
Chief Executive Officer - 85-12-31
More insiders
Pharmacare PLC is a Palestine-based company engaged in the pharmaceutical sector. The Company manufactures and distributes medical products, such as antibiotics, general and veterinary drugs. The Company owns and operates two distribution centers in Betunia and Gaza city; A drugstore based in Jerusalem, and licensed by the Ministry of Health; a science center in Gaza city; a marketing center in Betunia, which supports the activities of the Company and others, and representative offices in Russia, Belarus, Yemen and Romania. The Company’s products are exported to a range of regional and international markets. The Company's products include Klaricare, Ciprocare, Megacare Forte, Amoxicare and Fluoxicare, among others.
More about the company
  1. Stock Market
  2. Equities
  3. PHARMACARE Stock